J 104129 fumarate

Pricing Availability   Qty
说明: Potent and selective M3 antagonist
化学名: (αR)-α-Cyclopentyl-α-hydroxy-N-[1-(4-methyl-3-pentenyl)-4-piperidinyl]benzeneacetamide fumarate
纯度: ≥99% (HPLC)
说明书
引用文献 (1)
评论
文献 (1)

生物活性 for J 104129 fumarate

J 104129 fumarate is a potent M3 muscarinic receptor antagonist that displays ~ 120-fold selectivity over M2 receptors (Ki values are 4.2, 19 and 490 nM for human M3, M1 and M2 receptors respectively). Exhibits > 250-fold bronchial selectivity; inhibits ACh-induced bronchoconstriction but not ACh-induced bradycardia (KB values are 3.3 and 170 nM for rat trachea M3 and rat right atria M2 receptors respectively).

化合物库 for J 104129 fumarate

J 104129 fumarate is also offered as part of the Tocriscreen 2.0 Max. 了解 Tocris 化合物库的更多信息。

技术数据 for J 104129 fumarate

分子量 500.63
公式 C24H36N2O2.C4H4O4
储存 Store at +4°C
纯度 ≥99% (HPLC)
CAS Number 257603-40-0
PubChem ID 56972189
InChI Key HUCQUCITPHOUAC-DSSYAJFBSA-N
Smiles [H]OC(=O)\C=C\C(=O)O[H].C\C(C)=C\CCN1CCC(CC1)NC(=O)[C@@](O)(C1CCCC1)C1=CC=CC=C1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for J 104129 fumarate

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 50.06 100
ethanol 25.03 50

制备储备液 for J 104129 fumarate

以下数据基于产品分子量 500.63。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2 mL 9.99 mL 19.97 mL
5 mM 0.4 mL 2 mL 3.99 mL
10 mM 0.2 mL 1 mL 2 mL
50 mM 0.04 mL 0.2 mL 0.4 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for J 104129 fumarate

分析证书/产品说明书
选择另一批次:

参考文献 for J 104129 fumarate

参考文献是支持产品生物活性的出版物。

Mitsuya et al (1999) J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors. Bioorg.Med.Chem. 7 2555 PMID: 10632066

Mitsuya et al (2000) Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivatives. Bioorg.Med.Chem. 8 825 PMID: 10819171

Mitsuya et al (1999) Stereoselective synthesis of a new muscarinic M3 receptor antagonist, J-104129. Bioorrg.Med.Chem.Lett. 9 2037


If you know of a relevant reference for J 104129 fumarate, please let us know.

按产品操作查看相关产品

查看全部 M3 Receptor Antagonists

关键词: J 104129 fumarate, J 104129 fumarate supplier, Potent, selective, M3, antagonists, Muscarinic, Receptors, Acetylcholine, ACh, J104129, fumarate, 2507, Tocris Bioscience

1 篇 J 104129 fumarate 的引用文献

引用文献是使用了 Tocris 产品的出版物。 J 104129 fumarate 的部分引用包括:

Bader and Diener (2015) Novel aspects of cholinergic regulation of colonic ion transport. Biomed Res Int 3 e00139 PMID: 26236483


您是否知道使用了 Tocris J 104129 fumarate 的优秀论文? 请告知我们.

J 104129 fumarate 的评论

目前没有该产品的评论。 Be the first to review J 104129 fumarate and earn rewards!

Have you used J 104129 fumarate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.